1 code implementation • 26 Apr 2020 • Sai Krishna Gottipati, Boris Sattarov, Sufeng. Niu, Yashaswi Pathak, Hao-Ran Wei, Shengchao Liu, Karam M. J. Thomas, Simon Blackburn, Connor W. Coley, Jian Tang, Sarath Chandar, Yoshua Bengio
Over the last decade, there has been significant progress in the field of machine learning for de novo drug design, particularly in deep generative models.